![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Synergy Pharmaceuticals Inc. (SGYP) on Friday confirmed its previously announced agreement with Bausch Health Companies Inc. (BHC) has been approved by the U.S. Bankruptcy Court for the Southern...
By Stephen Nakrosis Bausch Health Companies Inc. (BHC) on Tuesday said it was selected as the successful bidder to acquire certain assets of Synergy Pharmaceuticals Inc. (SGYP), which voluntary...
By Josh Beckerman Shares of Synergy Pharmaceuticals Inc. (SGYP), which filed for bankruptcy last week, recently traded up 55% to 12 cents as the company's flagship product Trulance was...
By Charley Grant What's old is new again in pharma. Bausch Health, formerly known as Valeant Pharmaceuticals, is back in the acquisitions game after a long hiatus. The company announced...
By Chris Wack Bausch Health Companies Inc. (BHC) is buying substantially all of Synergy Pharmaceuticals Inc.'s (SGYP) assets, including all rights to TRULANCE (plecanatide), dolcanatide and...
By Chris Wack Bausch Health Companies Inc. (BHC) said Wednesday it agreed to buy substantially all of Synergy Pharmaceuticals Inc.'s (SGYP) assets for around $200 million in cash plus the...
Synergy Pharmaceuticals, Inc. (Nasdaq: SGYPD, SGYPU), a developer of new drugs to treat gastrointestinal disorders and diseases, announced the full exercise of the...
Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie PR Newswire NEW YORK, Dec. 13, 2011 NEW...
Synergy Pharmaceuticals, Inc. (Nasdaq:SGYPD, SGYPU), a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that it has filed a lawsuit...
Synergy Pharmaceuticals, Inc. (NASDAQ: SGYPD, SGYPU), a developer of new drugs to treat gastrointestinal disorders and diseases, announced the closing of its underwritten public...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions